BTI
British American Tobacco p.l.c.
NYSE · Consumer Defensive · Tobacco · GB
$55.81
−0.29%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 51.5B | 25.6B | 25.9B | 27.3B | 27.7B |
| Cost of Revenue | 11.5B | 4.2B | 4.4B | 4.9B | 4.8B |
| Gross Profit | 39.9B | 21.4B | 21.4B | 22.4B | 22.9B |
| Operating Expenses | |||||
| R&D Expense | 560.0M | 133.0M | 380.0M | 408.0M | 323.0M |
| SG&A Expense | 9.4B | 1.1B | 4.0B | 3.9B | 3.8B |
| General & Admin Expense | 3.1B | 31.0M | 2.8B | 2.7B | 2.7B |
| Selling & Marketing Expense | 2.2B | 1.1B | 1.1B | 1.2B | 1.2B |
| Other Expenses | 16.7B | 10.1B | 14.2B | 33.9B | 8.2B |
| Total Operating Expenses | 26.7B | 11.4B | 18.6B | 38.1B | 12.3B |
| Cost and Expenses | 38.3B | 15.6B | 23.1B | 43.0B | 17.1B |
| Operating Income (EBIT) | 13.2B | 10.0B | 2.7B | (15.8B) | 10.5B |
| Non-Operating | |||||
| Interest Income | 422.0M | 214.0M | — | 186.0M | 92.0M |
| Interest Expense | 3.1B | 1.9B | 1.1B | 1.9B | 1.7B |
| Net Interest Income | (2.7B) | (1.7B) | (1.1B) | (1.7B) | (1.6B) |
| Other Non-Op Income/Expense | (1.3B) | (138.0M) | 802.0M | (1.3B) | (1.2B) |
| Non-Operating Income (excl Interest) | (4.1B) | 241.0M | (1.9B) | (28.4B) | (979.0M) |
| EBT (Pre-Tax Income) | 11.9B | 9.9B | 3.5B | (17.1B) | 9.3B |
| Income Tax Expense | 2.2B | 2.1B | 357.0M | (2.9B) | 2.5B |
| Bottom Line | |||||
| Net Income | 9.6B | 7.8B | 3.1B | (14.4B) | 6.7B |
| Earnings from Cont. Ops | 9.6B | 7.8B | 3.2B | (14.2B) | 6.8B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 9.4B | 7.7B | 3.0B | (14.4B) | 6.6B |
| Per Share | |||||
| Basic EPS | $4.30 | $3.51 | $1.37 | ($6.49) | $2.93 |
| Diluted EPS | $4.29 | $3.49 | $1.36 | ($6.47) | $2.92 |
| Revenue Per Share | $23.77 | $11.71 | $11.68 | $12.28 | $12.27 |
| Shares | |||||
| Basic Shares Outstanding | 2.2B | 2.2B | 2.2B | 2.2B | 2.3B |
| Diluted Shares Outstanding | 2.2B | 2.2B | 2.2B | 2.2B | 2.3B |
| Profitability Metrics | |||||
| EBITDA | 20.5B | 11.8B | 7.7B | 13.3B | 12.2B |
| D&A | 4.9B | 2.0B | 3.1B | 634.0M | 724.0M |
| EBIT | 15.6B | 9.8B | 4.6B | 12.6B | 11.5B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026